Recon: FDA panel recommends withdrawing Makena; Merck affiliate under investigation in France over reformulation of thyroid drug
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy